BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//LifeSci Events - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:LifeSci Events
X-ORIGINAL-URL:https://lifescievents.com
X-WR-CALDESC:Events for LifeSci Events
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20261027T103000
DTEND;TZID=America/New_York:20261027T120000
DTSTAMP:20261014T141418Z
CREATED:20261008T180127Z
LAST-MODIFIED:20261014T141418Z
UID:3671-1793097000-1793102400@lifescievents.com
SUMMARY:ProKidney Virtual KOL Event: ASN Kidney Week Recap and Corporate Update
DESCRIPTION:Join ProKidney for a virtual event featuring renowned nephrology leader Katherine Tuttle\, MD\, who will join company management to discuss new insights into rilparencel’s mechanism of action from research presented at the American Society of Nephrology (ASN) Kidney Week 2026\, as well as the potential role of rilparencel in treating patients with advanced chronic kidney disease (CKD) and type 2 diabetes (T2D). \nAnthony Conway\, PhD\, ProKidney’s Head of Research and Development\, will review key findings from the company’s ASN presentations and discuss how they contribute to the understanding of rilparencel’s multifactorial mechanism of action. Dr. Tuttle will provide her clinical perspective on the findings\, the remaining unmet need for patients with advanced Stage 3b/4 CKD and T2D despite recent advances in standard of care\, and where rilparencel may fit within the evolving treatment paradigm. Company management will also provide a corporate update during the event. \nA live question and answer session will follow the formal presentations. Watch the webcast by clicking this link and logging in with the email address you used to register: https://lifescievents.com/event/pvn39ru/.
URL:https://lifescievents.com/event/pvn39ru/
LOCATION:Virtual\, Virtual
ATTACH;FMTTYPE=image/png:https://lifescievents.com/wp-content/uploads/2026/10/Events-Banners_2-37.png
END:VEVENT
END:VCALENDAR